Company Filing History:
Years Active: 2015-2024
Title: Innovations of Chongzhao Ran in Amyloid Imaging
Introduction
Chongzhao Ran is a prominent inventor based in Winchester, MA (US). He has made significant contributions to the field of biomedical imaging, particularly in the development of compounds that interact with amyloid beta, a protein associated with Alzheimer's disease. With a total of 7 patents to his name, Ran's work is paving the way for advancements in diagnostic imaging and therapeutic methods.
Latest Patents
One of Chongzhao Ran's latest patents focuses on "Half-curcuminoids as amyloid-β PET imaging agents." This innovation provides curcumin analogues that can interact with amyloid beta (Aβ) and reduce the copper-induced crosslinking of Aβ. The patent also outlines methods for using these compounds as imaging agents for amyloid beta and for treating diseases associated with this protein. Additionally, it includes methods for preparing both unlabeled and radiolabeled compounds that are useful for interacting with amyloid beta, along with pharmaceutical compositions.
Career Highlights
Chongzhao Ran is affiliated with The General Hospital Corporation, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and potential treatment of neurodegenerative diseases.
Collaborations
Ran collaborates with notable colleagues, including Anna V Moore and Jian Yang. Their combined expertise enhances the research efforts in the field of amyloid imaging and therapeutic development.
Conclusion
Chongzhao Ran's innovative work in the realm of amyloid imaging represents a significant step forward in the fight against Alzheimer's disease. His contributions are not only advancing scientific knowledge but also hold promise for future therapeutic applications.